Barclays’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-188,601
| Closed | -$6.18M | – | 5367 |
|
|
2022
Q2 | $6.18M | Buy |
188,601
+161,117
| +586% | +$5.09M | ﹤0.01% | 1230 |
|
|
2022
Q1 | $722K | Sell |
27,484
-16,602
| -38% | -$405K | ﹤0.01% | 2644 |
|
|
2021
Q4 | $1.05M | Buy |
44,086
+13,801
| +46% | +$341K | ﹤0.01% | 2805 |
|
|
2021
Q3 | $760K | Buy |
30,285
+7,538
| +33% | +$192K | ﹤0.01% | 2947 |
|
|
2021
Q2 | $591K | Sell |
22,747
-24,514
| -52% | -$667K | ﹤0.01% | 2979 |
|
|
2021
Q1 | $1.21M | Buy |
47,261
+9,735
| +26% | +$250K | ﹤0.01% | 2661 |
|
|
2020
Q4 | $751K | Sell |
37,526
-8,526
| -19% | -$167K | ﹤0.01% | 2962 |
|
|
2020
Q3 | $789K | Buy |
46,052
+8,191
| +22% | +$155K | ﹤0.01% | 2888 |
|
|
2020
Q2 | $824K | Buy |
37,861
+6,756
| +22% | +$155K | ﹤0.01% | 2931 |
|
|
2020
Q1 | $719K | Sell |
31,105
-19,599
| -39% | -$570K | ﹤0.01% | 3283 |
|
|
2019
Q4 | $1.67M | Buy |
50,704
+13,249
| +35% | +$425K | ﹤0.01% | 3187 |
|
|
2019
Q3 | $1.19M | Sell |
37,455
-1,105
| -3% | -$32.2K | ﹤0.01% | 3492 |
|
|
2019
Q2 | $991K | Buy |
38,560
+3,502
| +10% | +$89.2K | ﹤0.01% | 3698 |
|
|
2019
Q1 | $891K | Sell |
35,058
-7,475
| -18% | -$223K | ﹤0.01% | 3530 |
|
|
2018
Q4 | $1.45M | Sell |
42,533
-33,256
| -44% | -$1.08M | ﹤0.01% | 2739 |
|
|
2018
Q3 | $2.7M | Buy |
75,789
+20,533
| +37% | +$725K | ﹤0.01% | 2524 |
|
|
2018
Q2 | $1.91M | Sell |
55,256
-48,255
| -47% | -$1.69M | ﹤0.01% | 2628 |
|
|
2018
Q1 | $3.48M | Buy |
103,511
+57,540
| +125% | +$1.82M | ﹤0.01% | 1916 |
|
|
2017
Q4 | $1.76M | Buy |
45,971
+45,219
| +6,013% | +$1.81M | ﹤0.01% | 2550 |
|
|
2017
Q3 | $28K | Sell |
752
-6,479
| -90% | -$229K | ﹤0.01% | 5652 |
|
|
2017
Q2 | $270K | Sell |
7,231
-21,708
| -75% | -$784K | ﹤0.01% | 4116 |
|
|
2017
Q1 | $1.14M | Sell |
28,939
-27,677
| -49% | -$1.04M | ﹤0.01% | 2627 |
|
|
2016
Q4 | $1.97M | Buy |
56,616
+54,172
| +2,217% | +$2.13M | ﹤0.01% | 2133 |
|
|
2016
Q3 | $96K | Buy |
2,444
+2,399
| +5,331% | +$95.7K | ﹤0.01% | 4542 |
|
|
2016
Q2 | $2K | Sell |
45
-25,176
| -100% | -$843K | ﹤0.01% | 6008 |
|
|
2016
Q1 | $959K | Buy |
+25,221
| New | +$939K | ﹤0.01% | 2565 |
|
|
2015
Q4 | – | Sell |
-23,876
| Closed | -$932K | – | 6770 |
|
|
2015
Q3 | $932K | Buy |
23,876
+23,064
| +2,840% | +$980K | ﹤0.01% | 2778 |
|
|
2015
Q2 | $35K | Sell |
812
-154
| -16% | -$6.14K | ﹤0.01% | 5373 |
|
|
2015
Q1 | $38K | Sell |
966
-1,204
| -55% | -$44.4K | ﹤0.01% | 5465 |
|
|
2014
Q4 | $79K | Sell |
2,170
-1,501
| -41% | -$50.4K | ﹤0.01% | 5381 |
|
|
2014
Q3 | $107K | Buy |
3,671
+559
| +18% | +$15.4K | ﹤0.01% | 5273 |
|
|
2014
Q2 | $78K | Sell |
3,112
-1,123
| -27% | -$27.8K | ﹤0.01% | 5619 |
|
|
2014
Q1 | $106K | Buy |
4,235
+1,457
| +52% | +$36.7K | ﹤0.01% | 5401 |
|
|
2013
Q4 | $61K | Sell |
2,778
-11,122
| -80% | -$215K | ﹤0.01% | 6048 |
|
|
2013
Q3 | $195K | Sell |
13,900
-19,820
| -59% | -$265K | ﹤0.01% | 5060 |
|
|
2013
Q2 | $461K | Buy |
+33,720
| New | +$459K | ﹤0.01% | 4306 |
|
Other funds holding NTUS
Barclays's NTUS Position: Q3 2022 in Review
Barclays sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 188,601 shares — an estimated $6.18M sold.
Barclays first reported a position in NTUS in Q2 2013 and held it in 36 quarters. The position peaked at $6.18M in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Barclays reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Barclays sold 188,601 Natus Medical Inc shares in Q3 2022, an estimated $6.18M.
- Barclays first reported a position in Natus Medical Inc in Q2 2013 and held it in 36 quarters.
- Barclays's Natus Medical Inc position peaked at $6.18M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.